(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)], has been approved by the European Commission for the treatment of peanut allergy in the European … Read the full press release
Posted in European Union, Food & Beverage, Healthcare, News, Pharma & Biotech, Switzerland
Tagged Aimmune Therapeutics, Andrew Oxtoby, ARTEMIS, EC, EU, European Commission, European Union, food allergies, Greg Behar, Nestlé Health Science, OIT, oral desensitization therapy, oral immunotherapy, PALFORZIA, PALISADE, peanut allergy, peanut protein, SwissMedic, treatment of peanut allergy
IVD-seq project received 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) (PRESS RELEASE) GENT, 8-Dec-2020 — /EuropaWire/ — Fujirebio Europe announces that together with its partner OHMX.bio, a provider of cutting-edge “omics” solutions, have been awarded a 720K … Read the full press release
Posted in Belgium, Financial, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged Christiaan De Wilde, clinical in vitro diagnostics, clinical IVD expertise, diagnostics.”, Flanders Innovation & Entrepreneurship, Fujirebio Europe, genetic sequencing, genotyping, IVD, IVD modular solution, IVD solution, IVD-seq, IVD-seq project, Next generation sequencing, NGS, OHMX.bio, omics solutions, Prof. Gerben Menschaert, research grant, TGS, TGS IVD platform, third generation sequencing, VLAIO
Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating COVID-19 in addition to other diseases for which no therapeutic solutions are available (PRESS RELEASE) PARIS, 30-Nov-2020 — /EuropaWire/ — … Read the full press release
Posted in Banks, European Union, Financial, France, Healthcare, Investment, Luxembourg, News, Pharma & Biotech, Small Business
Tagged 3CL protease, AB Science SA, Alain Moussy, Ambroise Fayolle, anti-inflammatory, antiviral, chemotherapy, COVID-19, COVID-19 treatment, EIB, European Commission, European Fund for Strategic Investments, European Investment Bank, European Union, financing, health crisis, Horizon 2020, immunotherapeutic, inflammatory disease, innovationm, InnovFin, investments, kinase inhibitors, kinases, loan, macrophages, masitinib, microglia, neurological diseases, oncology, PKIs, RESEARCH, SARS-CoV-2, tyrosine kinase inhibitor
(PRESS RELEASE) COPENHAGEN, 26-Nov-2020 — /EuropaWire/ — Global biotechnology company Novozymes announces the appointment of Morten Enggaard Rasmussen as Executive Vice President of People, Sustainability & Brand succeeding Thomas Videbæk. Morten will take up his new position on 1 April, … Read the full press release
Posted in Denmark, Management, News, Pharma & Biotech, Science, Technology
Tagged appointment, biotechnology, Ester Baiget, human resources, Morten Enggaard Rasmussen, Novozymes, sustainability, Thomas Videbæk, Vestas
These collaborations are in response to the calls for innovation via AlmirallShare, the open innovation platform of Almirall and aim to identify new biosignatures and treatments for skin cancer and atopic dermatitis AlmirallShare is responsible for 50% of the private-public … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Spain
Tagged Almirall, AlmirallShare, atopic dermatitis, dermatological conditions, dermatological research, Dermatology, Dublin City University, Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, IDIBAPS, inflammatory diseases, Maribel Crespo, medical dermatology, molecular mechanisms, open innovation platform, Prof. Dr. Lluís Puig, Prof. Silvia Vidal, Prof. Tarl Prow, skin cancer, skin carcinoma, skin health, skin immune cell composition, skin transcriptome, skin tumor, Squamous cell Carcinoma, systemic biomarkers, systemic therapy, topical drugs, University College Dublin, University of Namur, University of Sheffield, University of South Australia, University of Turin
(PRESS RELEASE) CAMBRIDGE, 20-Nov-2020 — /EuropaWire/ — AstraZeneca (LON: AZN), a global, science-led biopharmaceutical company, has announced the US Food and Drug Administration (FDA) approval of its Imfinzi (durvalumab) for an additional dosing option, a 1,500mg fixed dose every four … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged bladder cancer, Dave Fredrickson, Imfinzi, Io, lung cancer, NSCLC, oncology, SCLC, Small cell lung cancer, Victoria M. Villaflor MD
The energy will be generated by the 179.9 MW TICO Wind Farm, located in the Spanish province of Zaragoza, Enel Green Power will be a “Green Enabler” for Novartis, supporting the company along its environmental sustainability journey (PRESS RELEASE) ROME, … Read the full press release
Posted in Energy, Gas & Oil, Environment, Industrial, Infrastructure & Utilities, Italy, News, Pharma & Biotech, Switzerland, Technology
Tagged carbon-neutrality, climate change, Enel Green Power, Enel Group, environmental sustainability, Green Enabler, greenhouse gas, Javier Vaquerizo, Montse Montaner, Novartis, renewable electricity, renewable energy, renewable power, sustainability, TICO Wind Farm, virtual power purchase agreement, VPPA, wind farm, Zaragoza
Attractive portfolio with strong and successful models of the human skin Global dissemination of regulatory approved alternative test methods Important step towards the worldwide use and distribution of alternative test methods (PRESS RELEASE) DÜSSELDORF, 3-Nov-2020 — /EuropaWire/ — Henkel (ETR: … Read the full press release
Strategic partnership for digital transformation of pharmaceutical processes Operational usage of digital plant data New Smart Engineering Services (SES) New modules improve integration in the value chain (PRESS RELEASE) NUREMBERG/ LIEBOCH/ GRAZ, 3-Nov-2020 — /EuropaWire/ — Siemens and Zeta Gmbh … Read the full press release
Posted in Austria, Germany, Infrastructure & Utilities, Internet & Online, News, Pharma & Biotech, Technology
Tagged Bart Moors, biopharmaceutical, Comos, data management, digital engineering, Digital Enterprise Portfolio, digital planning, digital transformation, digitalization, Evelyne Kadel, Martin Mayer, Martin Meyer, Pharmaceutical, pharmaceutical processes, plant engineering software, Siemens, Smart Engineering Services, Zeta
Palette Life Sciences provides valuable information regarding vesicoureteral reflux (VUR) to paediatric urologists in France, Germany, Italy and Spain (PRESS RELEASE) SANTA BARBARA, CALIF. / STOCKHOLM, 27-Oct-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company … Read the full press release
Posted in Education, France, Germany, Healthcare, Internet & Online, Italy, News, Pharma & Biotech, Spain, Sweden
Tagged Barrigel®, CE-Mark, Chelsea & Westminster, colorectal conditions, Deflux, Deflux Learning Center, Deflux®, dextranomer, Dr. Marie-Klaire Farrugia, Dx, educational resources, healthcare community, healthcare providers, Imperial College Hospitals, interventional oncology, Lidbree ™, life sciences, medical solutions, microspheres, NASHA®, online resources, online resources for healthcare providers, pae, paediatric, paediatric urinary condition, Palette Life Sciences, physicians, polysaccharides, Q-Med, radiotherapy, Rich Low, Solesta®, urine reflux, urogynaecology disorders, urology, UTI, vesicoureteral reflux, VUR
(PRESS RELEASE) VEVEY, 14-Oct-2020 — /EuropaWire/ — Nestlé has successfully closed the acquisition of biopharmaceutical company, Aimmune Therapeutics, Inc. (Nasdaq: AIMT). The company which specializes in developing and bringing new treatments to people with potentially life-threatening food allergies joins Nestlé … Read the full press release
Posted in Investment, Management, News, Pharma & Biotech, Science, Switzerland
Tagged acquisition, Aimmune Therapeutics, allergic reactions, allergies, AlMab7195, anaphylaxis, Andrew Oxtoby, Arachis hypogaea, asthma, EM, Eosinophilic Gastrointestinal Disease, European Medicines Agency, FDA, Greg Behar, monoclonal antibody, Nestlé, Nestlé Health Science, NHSc, oral immunotherapy, PALFORZIA®, Peanut Allergen Powder-dnfp, Pharmaceutical, science-bassed nutritional solutions, Swiss Agency for Therapeutic Products, SwissMedic, treating peanut allergy
In a post-hoc analysis of HAWK and HARRIER, fewer Beovu (brolucizumab) patients had early persistent fluid (12.5% vs. 20.4% of aflibercept patients), defined as the presence of intra-retinal fluid and/or sub-retinal fluid through week 12 of treatment1 Patients with early persistent fluid treated with Beovu experienced greater … Read the full press release
(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase 1 safety and immunogenicity … Read the full press release
Posted in Austria, European Union, France, Germany, Healthcare, Hungary, News, Pharma & Biotech, Science, United Kingdom
Tagged biotechnology, CEBINA, Central European Biotech Incubator and Accelerator, clinical testing, Clinical Trail, Diarrhoeal diseases, Enterotoxigenic E. coli, ETEC, European Vaccine Initiative, Eveliqure, Eveliqure Biotechnologies, Eveliqure Biotechnologies GmbH, Frank Malinoski, Gábor Somogyi, Healthcare, Horizon 2020, icddr b, PATH, Pharma & Biotech, science, Shigella, ShigETEC, SHIGETECVAX, Travel Diarrhea, University of Gothenburg, vaccine candidate, Wellcome Trust
Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system (PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused … Read the full press release
Posted in Belgium, European Union, France, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Advanced purchase agreement, COVID-19, COVID-19 vaccine, EC, European Commission, GSK, influenza vaccine, Sanofi, vaccine
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. The test targets antibodies against the spike protein. This is the focus of vaccines in development … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Switzerland
Tagged Anti-SARS-CoV-2 S, antibodies, antibody test, COVID-19, Elecsys Anti-SARS-CoV-2 S test, Elecsys Anti-SARS-CoV-2 serology test, Elecsys®, Emergency Use Authorisation, EUA, FDA, Roche, SARS-CoV-2, SARS-CoV-2 vaccine, Thomas Schinecker, vaccines
Libtayo is the first investigational medicine to show a clinical benefit in advanced basal cell carcinoma following treatment with a hedgehog inhibitor in a prospective trial 31% objective response rate seen in trial patients, and an estimated 85% of responses … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech, Science
Tagged advanced basal cell carcinoma, Alexander Stratigos M.D., Andreas Sygros Hospital, basal cell carcinoma, BCC, biopharmaceutical, cemiplimab, ESMO Virtual Congress 2020, European Society for Medical Oncology, hedgehog inhibitor, HHI therapy, inhibitor, Libtayo®, Regeneron, Sanofi, University of Athens Medical School
(PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced it has appointed Dr. Jean-Christophe Rufin as President of the Sanofi Espoir Corporate Foundation, aimed at reducing inequalities in health … Read the full press release
Posted in France, Healthcare, Management, News, Pharma & Biotech, Society
Tagged access to healthcare, appointment, Brazilian Academy of Letters, Catholic University of Louvain, Dr. Jean-Christophe Rufin, fight against pediatric cancers, Laval University, reduce health inequalities, Royal Academy of Medicine of Belgium, Sanofi, Sanofi Espoir Corporate Foundation, Serge Weinberg, Xavier Darcos
(PRESS RELEASE) PARIS, 28-Aug-2020 — /EuropaWire/ — French multinational pharmaceutical company Sanofi announces its intention to commence a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of Principia Biopharma Inc. for $100 per share … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech
Tagged acquisition, biopharmaceutical, BofA Securities, BTK inhibitor, Centerview Partners LLC, Cooley LLP, Evercore, Gotshal & Manges LLP, Healthcare, immune thrombocytopenia, immune-mediated diseases, ITP, Kortex Acquisition Corp., MERGER, Merger Agreement, outstanding shares, Principia Biopharma Inc., rilzabrutinib, Sanofi, stock, Tailored Covalency®, tender offer, Weil
Further strengthens core R&D areas of autoimmune and allergic diseases Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple sclerosis (MS), making commercialization more efficient and eliminating future royalty payments Allows expansion of SAR442168 development program into other central … Read the full press release
Posted in Business, France, Healthcare, Investment, News, Pharma & Biotech
Tagged acquisition, allergic diseases, Arnaud Delepine, Ashleigh Koss, autoimmune diseases, biopharmaceutical, BofA Securities, Bruton tyrosine kinase, BTK inhibitor, BTK inhibitor ‘168, Centerview Partners LLC, Christopher Chai, commercialization, Cooley LLP, Eva Schaefer-Jansen, Evercore, Fara Berkowitz, Felix Lauscher, Gotshal & Manges LLP, John Reed M.D. Ph.D., Martin Babler, MS, multiple sclerosis, Nicolas Kressmann, pathophysiology, Paul Hudson, Paul Laland, Pharmaceutical, Principia, Principia Biopharma, PRN473 Topical, rilzabrutinib, Sanofi, SAR442168, Suzanne Greco, Weil, Yvonne Naughton
(PRESS RELEASE) CAMBRIDGE, 14-Aug-2020 — /EuropaWire/ — Global science-led biopharmaceutical company AstraZeneca (LSE/STO/NYSE: AZN) has announced it signed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the AZD1222 COVID-19 vaccine. Building … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?